The Hartford: An Excellent Insurer Priced Like One
Before the Gates
The Hartford sells commercial property-and-casualty insurance to small and mid-sized American businesses — workers’ compensation, commercial packages, general liability — alongside personal lines through its exclusive AARP partnership and a group benefits franchise in life and disability. The economics are the insurance two-engine: collect premiums, hold the combined ratio below 100, and invest the float in a bond-heavy portfolio. In 2025 both engines fired — Business Insurance ran an 88.8 combined ratio, Personal Insurance an 88.7, and the small-business unit alone wrote $6 billion in premium.
That is the business. Whether it is a good business at a good price is what the gates are for.
Gate 1: Circle of Competence
The test has two layers. First, can the information be obtained? Yes — SEC filings, earnings calls, statutory loss-ratio disclosures, and industry rate data allow the business, the balance sheet, and the competitive map to be reconstructed without guesswork.
Second, can the future be predicted? Here the answer is unusually comfortable for a financials name. Small businesses must buy workers’ comp by law; demand moves with employment and does not go away. It is a mature industry where regulation, loss data, and agency distribution form real entry barriers. The statement “in ten years, American small businesses will still be legally required to carry workers’ comp, and The Hartford will still be a top underwriter in that market” is analysis, not a bet.
One caveat earns its place: combined ratios cycle. Any judgment here must be made on cycle-average earnings, never on a single year’s print. That caveat turns out to matter a great deal by Gate 4.
Gate 2: Moat
The moat has two sources. The first is cost advantage. Small-ticket insurance is a unit-cost game — underwriting and claims handling per policy must be cheap — and The Hartford’s base of 1.3 million-plus small-business customers, decades of loss data, and a digital underwriting platform (rated the top digital insurer for small business) give it scale economics that are difficult to replicate. The second is intangible: a 200-year-plus brand, the exclusive AARP channel, and the position of second-largest commercial multi-peril underwriter in the United States, woven into a dense agency network.
Evidence of pricing power is quantifiable. The company held renewal pricing on non-workers’-comp commercial lines at roughly +6% while still running the small-business book at an 88.9 underwriting combined ratio — rate increases and volume retention at the same time. A five-year average ROE of 16.3% with a standard deviation of just 3.3% is, for a cyclical industry, the arithmetic shadow of underwriting discipline. Later data confirmed the durability: the Business Insurance underwriting combined ratio has held in the high 80s across the cycle (88.3 in 2022, 88.1 in 2025, 89.3 in Q2 2026) while small-business premiums grew +8%.
The direction is nuanced. The moat is holding to widening gently, but with pressure: the CEO himself has acknowledged intensifying competition in the SME market from both incumbents and entrants, and 2026 has brought a softening in commercial rates. AI-native players have begun penetrating small-business and workers’ comp lines. The honest read: AI, for now, favors the strong — data-driven automated underwriting suits this business, and The Hartford owns both the loss data and the distribution — but the scenario where AI commoditizes underwriting skill and erodes the value of proprietary data stays on the watch list.
Gate 3: Management
Christopher Swift has run the company since 2015, and the record reads like a checklist. He wound down volatile legacy variable-annuity businesses. He bought Navigators in 2019 to bolster specialty lines, then refrained from large M&A. When Chubb offered $65 per share in 2021, he declined — and with the stock around $140, that refusal has been vindicated.
Capital returns have been steady and disciplined: fourteen consecutive years of dividend increases (a 10-year average of +13% annually), and a buyback approved in July 2024 that retired 6.6% of shares at an average of about $127 — roughly twice book value per share of $66.58, but only about 10x owner earnings. That is a rational price, not an imperial one. A retained-earnings test passes comfortably: over five years the stock rose about 2.5x while ROE stayed in the mid-teens.
Candor checks out too. The company disclosed and reserved for social inflation exposure without evasion, including a $70 million addition in Q1 2026 for legacy abuse-related liability. Total shareholder return via dividends and buybacks runs around 5.8%. More recently, the board approved a $4.2 billion buyback through December 2028, quarterly repurchases ran $475 million, and the pending sale of Hartford Funds to Wellington (expected to close in Q1 2027) sharpens focus on the core. Buyback pricing remains within the discipline threshold.
Gate 4: Price
Here the story turns. Screening owner earnings come in at $3.85 billion, an owner-earnings yield of 9.81% at the current $39.28 billion market cap — comfortably above the 10-year Treasury’s 4.66%. But that numerator sits at a hard-market peak: 2025 core EPS was $13.42 (+30%), ROE 19.4%, and Q2 2026 TTM ROE 18.7%. Favorable prior-year development is shrinking ($146 million falling to $52 million), renewal rate softening is underway, and legacy reserve additions have begun. Normalizing conservatively to $3.3–3.5 billion (center $3.4 billion) yields an owner-earnings yield of 8.40–8.91%.
Value that normalized figure at 12x for a low-growth franchise and intrinsic value is about $40.8 billion; a no-growth 10x floor sits at $34 billion. Against the center, the current price carries a discount of just 3.7%. The 30% margin-of-safety standard is missed — badly. The buy line sits near $104 per share (roughly $28.6 billion market cap); the current price of $143.28 is 37.5% above it.
And one warning light is already lit. Two consecutive quarters of adverse prior-year development have effectively appeared in general liability (+$46 million in Q2, on excess/umbrella large-loss frequency) and commercial auto (+$26 million) — after the $70 million legacy charge in Q1. Workers’ comp favorable development ($110 million in the first half) offsets this so net development remains favorable, but the pattern is indistinguishable from the early signature of social inflation eating reserves — the thesis’s single largest vulnerability. A third adverse quarter in general liability would force the normalized figure down and the buy line with it. The rest of the watch list is specific: a Business Insurance combined ratio persistently above 93, renewal pricing below loss trend for four straight quarters, a rate-softening cycle deeper than assumed, and buybacks above 12x owner earnings.
Verdict
Watch. Gates one through three are passed with genuine conviction — a scale-and-data moat in a regulated, inertial market, run by people who have turned down $65 a share and repurchased stock at sensible prices. The failure is singular: at 3.7% below the center of intrinsic value, this is a fair price for an excellent company, not a discount. And a 30% margin of safety is precisely the buffer needed to absorb the possibility that the reserve clock now ticking in general liability makes even the normalized estimate optimistic. The price does not forgive errors from here.
What would change it: a price below roughly $104 per share — or evidence that general liability reserve development has stabilized favorably, in which case the buy line itself deserves recalculation. Until one of those arrives, the position of this company on the ledger is admiration, not ownership.
This analysis is AI-generated, educational, and not investment advice. Figures may contain errors or be delayed. Disclaimer